美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ligand Pharmaceuticals Incorporated

0.1400

0.0000

成交量：- -

成交额：- -

市值：- -

市盈率：- -

高：0.1400

开：0.1400

低：0.1400

收：0.1400

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

Ligand Pharmaceuticals Incorporated2025财年第一财季实现净利润-42.45百万美元，同比减少149.28%

Ligand Pharmaceuticals Incorporated盘中异动大幅下挫5.00%报100.34美元

Ligand Pharmaceuticals Incorporated跌3.97% 股价跌破100美元大关

Ligand Pharmaceuticals Incorporated涨4.14% 股价突破100美元大关

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/LGNZZ"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LGNZZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGNZZ\",,,,,undefined,":{"symbol":"LGNZZ","market":"US","secType":"STK","nameCN":"Ligand Pharmaceuticals Incorporated","latestPrice":0.14,"timestamp":1747923840000,"preClose":0.14,"halted":0,"volume":0,"delay":15,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"05-22 10:24:00 EDT 延时","open":0.14,"high":0.14,"low":0.14,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1747944000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.14,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGNZZ\",,,,,undefined,":{"symbol":"LGNZZ","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.14,"amplitude":0,"preClose":0.14,"low":0.14,"week52Low":0.1,"pbRate":"--","week52High":0.196,"institutionHeld":0,"latestPrice":0.14,"eps":0,"divideRate":0,"volume":0,"delay":15,"open":0.14,"prevYearClose":0.1325,"prevWeekClose":0.139,"prevMonthClose":0.13,"prevQuarterClose":0.14,"fiveDayClose":0.139,"twentyDayClose":0.13,"sixtyDayClose":0.1227},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LGNZZ\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LGNZZ\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536584228","title":"Ligand Pharmaceuticals Incorporated2025财年第一财季实现净利润-42.45百万美元，同比减少149.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536584228","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536584228?lang=zh_cn&edition=fundamental","pubTime":"2025-05-18 00:00","pubTimestamp":1747497624,"startTime":"0","endTime":"0","summary":"5月18日，Ligand Pharmaceuticals Incorporated公布财报，公告显示公司2025财年第一财季净利润为-42.45百万美元，同比减少149.28%；其中营业收入为45.33百万美元，同比增加46.32%，每股基本收益为-2.21美元。从资产负债表来看，Ligand Pharmaceuticals Incorporated总负债1.10亿美元，其中短期债务883000.00美元，资产负债比为8.23，流动比率为0.06。机构评级：截至2025年5月18日，当前有8家机构对Ligand Pharmaceuticals Incorporated目标价做出预测，其中目标均价为143.88美元，其中最低目标价为135.00美元，最高目标价为157.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000125a4821d8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000125a4821d8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGND","LGNXZ","LGNZZ","LGNYZ","LGNDZ"],"gpt_icon":0},{"id":"2533137122","title":"Ligand Pharmaceuticals Incorporated盘中异动 大幅下挫5.00%报100.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533137122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533137122?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:58","pubTimestamp":1746712696,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时58分，Ligand Pharmaceuticals Incorporated股票出现异动，股价急速下挫5.00%。截至发稿，该股报100.34美元/股，成交量1.413万股，换手率0.07%，振幅6.03%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为3.15%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821582094f095a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821582094f095a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0566484027.USD","LGND","LGNDZ","LGNXZ","LU1559883803.SGD","LGNZZ","BK4139","LGNYZ"],"gpt_icon":0},{"id":"2526870597","title":"Ligand Pharmaceuticals Incorporated跌3.97% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2526870597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526870597?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 23:13","pubTimestamp":1744298006,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日23时13分，Ligand Pharmaceuticals Incorporated股票出现异动，股价快速下跌3.97%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为2.49%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Pasithea Therapeutics Corp.、Pmgc Holdings Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3383.92%、2231.66%、313.59%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc.，振幅分别为81.65%、71.43%、70.97%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410231327a6b6b9db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410231327a6b6b9db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0566484027.USD","LGNXZ","BK4139","LGNYZ","LU1559883803.SGD","LGNDZ","LGND","LGNZZ","BK4007"],"gpt_icon":0},{"id":"2526311483","title":"Ligand Pharmaceuticals Incorporated涨4.14% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2526311483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526311483?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 01:27","pubTimestamp":1744219621,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日01时27分，Ligand Pharmaceuticals Incorporated股票出现波动，股价大幅上涨4.14%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Phio Pharmaceuticals Corp.、Humacyte, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Hepion Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Aditxt, Inc.较为活跃，换手率分别为7456.81%、2932.86%、226.55%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Moolec Science Sa C/Wts 、Hepion Pharmaceuticals, Inc.，振幅分别为138.61%、108.26%、80.93%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041001270194d0f9f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041001270194d0f9f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNYZ","LGNXZ","LGND","BK4007","LGNDZ","LU1559883803.SGD","LGNZZ","BK4139","LU0566484027.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LGNZZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"LGNZZ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":null},{"date":"2024-08-06","symbol":"LGNZZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722974400000,"name":null,"time":"盘后","dateTimestamp":1722916800000,"actualEps":null},{"date":"2024-05-07","symbol":"LGNZZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715112000000,"name":null,"time":"盘后","dateTimestamp":1715054400000,"actualEps":null},{"date":"2022-11-07","symbol":"LGNZZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1667854800000,"name":null,"time":"盘后","dateTimestamp":1667797200000,"actualEps":null},{"date":"2022-08-08","symbol":"LGNZZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1659988800000,"name":null,"time":"盘后","dateTimestamp":1659931200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LGNZZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LGNZZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1744257600000}}}